Signal transduction in the liver: C/EBPβ modulates cell proliferation and survival

Hepatology

Volumn 37, Issue 4, 2003, Pages 731-738

  Buck, Martina ^a   Chojkier, Mario ^a,b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; ISOPROTEIN; LEUCINE ZIPPER PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE;

ANIMAL CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; HUMAN; LIVER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION;

EID: 0037382539     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2003.50155     Document Type: Review

References (70)

1. Johnson GL, Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 2002;298:1911-1934.
2. Hunter T, Karin M. The regulation of transcription by phosphorylation. Cell 1992;70:375-387.
3. Chojkier M. Regulation of liver-specific gene expression. In: Boyer J, Ockner R, eds. Progress in Liver Diseases. Orlando: W.B. Saunders, 1995:37-61.
4. Whitmarsh A, Davis R. A central control for cell growth. Nature 2000; 403:255-256.
5. Park S-H, Zarrinpar A, Lim WA. Rewiring MAP kinase pathways using alternative scaffold assembly mechanisms. Science 2003;299:1061-1064.
6. Duesbery NS, Webb CP, Leppla SH, Gordon VM, Klimpel KR, Copeland TD, Ahn NG, et al. Proteolyric inactivation of MAP-kinase-kinase by anthrax lethal factor. Science 1998;280;734-737.
7. Ashkenazi A, Dixit V. Death receptors: signaling and modulation. Science 1998;281:1305-1308.
8. Rojas M, Yao S, Lin Y-Z. Controlling epidermal growth factor (EGF)-stimulated Ras activation in intact cells by a cell-permeable peptide mimicking phosphorylated EGF receptor. J Biol Chem 1996;271:27456-27461.
9. Buck M, Poli V, van der Geer P, Chojkier M, Hunter T. Phosphorylation of rat serine 105 or mouse threonine 217 in C/EBPβ is required for hepatocyte proliferation induced by TGFα. Mol Cell 1999;4:1087-1092.
10. Buck M, Poli V, Hunter T, Chojkier M. C/EBPβ phosphorylation by RSK creates a functional XEXD caspase inhibitory box critical for cell survival. Mol Cell 2001;8:807-816.
11. Bonni A, Brunet A, West A, Datta S, Takasu M, Greenberg M. Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms. Science 1999;286:1358-1362.
12. Chen R-H, Abate C, Blenis J. Phosphorylation of the c-Fos transrepression domain by mitogen-activated protein kinase and 90-kDa ribosomal S6 kinase. Proc Natl Acad Sci U S A 1993;90:10952-10956.
13. Nakajima T, Fukamizu A, Takahashi J, Gage FH, Fisher T, Blenis J, Montminy MR, et al. The signal-dependent coactivator CBP is a nuclear target for pp90RSK. Cell 1996;86:465-474.
14. Jhappan C, Stahle C, Harkins RN, Fausto N, Smith GH, Merlino GT. TGF alpha overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas. Cell 1990; 61:1137-1146.
15. Laird AD, Brown PI, Fausto N. Inhibition of tumor growth in liver epithelial cells transfected with a transforming growth factor alpha antisense gene. Cancer Res 1994;54:4224-4232.
16. Couzin J. Smart weapons prove tough to design. Science 2002;298:522-525.
17. Sebolt-Leopold JS, Dudley DT, Herrera R, Van Becelaere K, Wiland A, Gowan RC, Tecle H, et al. Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo. Nature Medicine 1999;5:810-816.
18. Duesbery NS, Resau J, Webb CP, Koochekpour S, Koo HM, Leppla SH, Vande Woude GF, et al. Suppression of ras-mediated transformation and inhibition of tumor growth and angiogenesis by anthrax lethal factor, a proteolytic inhibitor of multiple MEK pathways. Proc Natl Acad Sci U S A 2001;98:4089-4094.
19. Zhu S, Yoon K, Sterneck E, Johnson PF, Smart RC. CCAAT/enhancer binding protein-beta is a mediator of keratinocyte survival and skin tumorigenesis involving oncogenic Ras signaling. PNAS 2002;99:207-212.
20. Behrens A, Sibilia M, David J-P, Tronche F, Schultz G, Wagner EF. Impaired postnatal hepatocyte proliferation and liver regeneration in mice lacking c-jun in the liver. EMBO J 2003;21;1782-1790.
21. Chen J, Jackson PK, Kirschner MW, Dutta A. Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA. Nature 1995;374: 386-388.
22. Roy SK, Hu J, Meng Q, Xia Y, Shapiro PS, Reddy SPM, Platanias LC, et al. MEKK1 plays a critical role in activating the transcription factor C/EBP-β-dependent gene expression in response to IFN-γ. PNAS 2002; 99:7495-7950.
23. Screpanti I, Romani L, Musiani P, Modesti A, Fattori E, Lazzaro D, Sellitto C, et al. Lymphoproliferative disorder and imbalanced T-helper response in C/EBPβ-deficient mice. EMBO J 1995;14:1932-1941.
24. McKnight SL. McBindall - a better name for CCAAT/enhancer binding proteins? Cell 2001;107:259-261.
25. Mueller CR, Maire P, Schibler U. DBP, a liver-enriched transcriptional activator, is expressed late in ontogeny and its tissue specificity is determined posttranscriptionally. Cell 1990;61:279-291.
26. Inaba T, Roberts WM, Shapiro LH, Jolly KW, Raimondi SC, Smith SD, Look AT, et al. Fusion of the leucine zipper gene HLF to the E2A gene in human acute B-lineage leukemia. Science 1992;257:531-534.
27. Barone MV, Crozat A, Tabaee A, Philipson L, Ron D. CHOP (GADD 153) and its oncogenic variant, TLS-CHOP, have opposing effect on the induction of G1/S arrest. Genes Dev 1994;8:453-464.
28. Crozat A, Aman P, Mandahl N, Ron D. Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma. Nature 1993;363: 640-644.
29. Christy RJ, Yang VW, Ntambi JM, Geiman DE, Landschulz WH, Friedman AD, Nakabeppu Y, et al. Differentíation-induced gene expression in 3T3-L1 preadipocytes: CCAAT/enhancer binding protein interacts with and activates the promoters of two adipocyte-specific genes. Genes Dev 1989;3:1323-1335.
30. Porse BT, Pedersen TA, Xu X, Lindberg B, Wewer UM, Friis-Hansen L, Nerlov C, et al. E2F repression by C/EBPα is required for adipogenesis and granulopoiesis in vivo. Cell 2001;107:247-258.
31. Pabst T, Mueller BU, Zhang P, Radomska HS, Narravula S, Schnittger S, Behre G, et al. Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPa), in acute myeloid leukemia. Nat Genet 2001;27:263-270.
32. Wang H, Iakova P, Wilde M, Welm A, Goode T, Roesler WJ, Timchenko NA, et al. C/EBPα arrests cell proliferation through direct inhibition of cdk2 and cdk4. Mol Cell 2001;8:817-828.
33. Descombes P, Chojkier M, Lichtsteiner S, Falvey E, Schibler U. LAP, a novel member of the C/EBP gene family, encodes a liver-enriched transcriptional activator protein. Genes Dev 1990;4:1541-1551.
34. Poli V, Mancini FP, Cortese R. IL6-DBP, a nuclear protein involved in interleukin-6 signal transduction, defines a new family of leucine zipper proteins related to C/EBP. Cell 1990;63:643-653.
35. Trautwein C, Caelles C, van der Geer P, Hunter T, Karin M, Chojkier M. Transactivation by NF-IL6/LAP is enhanced by phosphorylation of its activation domain. Nature 1993;364:544-547.
36. Akira S, Isshiki H, Sugita T, Tanabe O, Kinoshita S, Nishio Y, Nakajima T, et al. A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family. EMBO J 1990;9:1897-1906.
37. Buck M, Turler H, Chojkier M. LAP (NF-IL6), a tissue-specific transcriptional activator, is an inhibitor of hepatoma cell proliferation. EMBO J 1994;13:851-860.
38. WAF1/CIP1 via C/EBPβ. Nat Med 1997;3:1233-1241.
39. An MR, Hsieh C-C, Reisner PD, Rabek JP, Scott SG, Kuninger DT, Papaconstantinou J, et al. Evidence for posttranscriptional regulation of C/EBPα and C/EBPβ isoform expression during the lipopolysaccharide-mediated acute-phase response. Mol Cell Biol 1996;16:2295-2306.
40. Descombes P, Schibler UA. A liver-enriched transcriptional activator protein, LAP, and a transcriptionally inhibitory protein, LIP, are translated from the same mRNA. Cell 1991;67:569-579.
41. Lin FT, MacDougald OA, Diehl AM, Lane MD. A 30-kDa alternative translation product of the CCAAT/enhancer binding protein message: transcriptional activator lacking antimitotic activity. Proc Natl Acad Sci U S A 1993;90:9606-9610.
42. Diehl AM, Yang SQ. Regenerative changes in C/EBP alpha and C/EBP beta modulate expression binding to the C/EBP site in the c-fos promoter. HEPATOLOGY 1994;19:447-456.
43. Alonzi T, Maritano D, Gorgoni B, Rizzuto G, Libert C, Poli V. Essential role of STAT3 in the control of the acute-phase response as revealed by inducible gene activation in the liver. Mol Cell Biol 2001;21:1621-1632.
44. Timchenko NA, Wilde M, Nakanishi M, Smith JR, Darlington G. CCAAT/enhancer binding protein alpha (C/EBP alpha) inhibits cell proliferation through the p21 (WAF-1/CIP-1/SDI-1) protein. Genes Dev 1996;10:804-815.
45. Greenbaum LE, Cressman DE, Harber BA, Taub R. Coexistence of C/EBPa, β growth-induced proteins and DNA synthesis in hepatocytes during liver regeneration. J Clin Invest 1995;96:1351-1365.
46. Nakajima T, Kinoshita S, Sasagawa T, Sasaki K, Naruto M, Kishimoto T, Akira S, et al. Phosphorylation at threonine-235 by a ras-dependent mitogen-activated protein kinase cascade is essential for transcription factor NF-IL6. Proc Natl Acad Sci U S A 1993;90:2207-2211.
47. Wegner M, Cao Z, Rosenfeld MG. Calcium-regulated phosphorylation within the leucine zipper of C/EBP. Science 1992;256:370-373.
48. Metz R, Ziff E. cAMP stimulates the C/EBP-related transcription factor rNFIL-6 to trans-locate to the nucleus and induce c-fos transcription. Genes Dev 1991;5:1754-1766.
49. Katz S, Kowenz-Leutz E, Muller C, Meese K, Ness SA, Leutz A. The NF-M transcription factor is related to C/EBPβ and plays a role in signal transduction, differentiation and leukemogenesis of avian myelomonocytic cells. EMBO J 1993;12:1321-1332.
50. Trautwein C, van der Geer P, Karin M, Hunter T, Chojkier M. Protein kinase A and C site-specific phosphorylations of LAP (NF-IL6) modulate its binding affinity to DNA-recognition elements. J Clin Invest 1994;93: 2554-2561.
51. Buck M, Zhang L, Hunter T, Chojkier M. Nuclear export of phosphorylated C/EBPβ mediates the inhibition of albumin expression by TNFα. EMBO J 2001;20:6712-6723.
52. Yin M, Yang SQ, Lin HZ, Lane MD, Chatterjee S, Diehl A. Tumor necrosis factor a promotes nuclear localization of cytokine-inducible CCAAT/Enhancer binding protein isoforms in hepatocytes. J Biol Chem 1996;271:17974-17978.
53. Chinery R, Brockman JA, Dransfield DT, Coffey RJ. Antioxidant-induced nuclear translocation of CCAAT/enhancer-binding protein beta. A critical role for protein kinase A-mediated phosphorylation or Ser299. J Biol Chem 1997;272:30356-30361.
54. Kowenz-Leutz E, Twamley G, Ansieau S, Leutz A. Novel mechanism of C/EBP beta (NF-M) transcriptional control: activation through derepression. Genes Dev 1994;8:2781-2791.
55. Muller C, Kowenz-Leutz E, Grieser-Ade S, Graf T, Leutz A. NF-M (chicken C/EBPβ) induces eosinophilic differentiation and apoptosis in a hematopoietic progenitor cell line. EMBO J 1995;14:6127-6135.
56. Natsuka S, Akira S, Nishio Y, Hashimoto S, Sugita T, Isshiki H, Kishimoto T, et al. Macrophage differentiation-specific expression of NF-IL6, a transcription factor for interleukin-6. Blood 1992;79:460-466.
57. Fausto N, Webber E. Liver Regeneration. In: Arias IM, Boyer JL, Fausto N, Jakoby W, Schachter D, Shafritz DA, eds, The Liver: Biology and Pathobiology. New York: Raven Press, 1994:1059-1086.
58. Haber AH, Mohn KL, Diamond RH, Taub R. Induction patterns of 70 genes during 9 days after hepatectomy define the temporal course of liver regeneration. J Clin Invest 1993;91:1319-1326.
59. Greenbaum L, Li W, Cressman D, Peng Y, Ciliberto G, Poli V, Taub R, et al. CCAAT enhancer-binding protein β is required for normal hepatocyre proliferation in mice after partial hepatectomy. J Clin Invest 1998;102: 996-1007.
60. Graves L, Guy H, Kozlowski P, Huang M, Lazarowski E, Pope R, Collins MA, et al. Regulation of carbamoyl phosphate synthetase by MAP kinase. Nature 2000;403:328-332.
61. Bhatt R, Ferrell J. The protein kinase p90 Rsk as an essential mediator of cytostatic factor activity. Science 1999;286:1362-1365.
62. Sassone-Corsi P, Mizzen C, Cheung P, Crosio C, Monaco L, Jacquot S, Hanauer A, et al. Requirement of Rsk-2 for epidermal growth factor-activated phosphorylation of histone H3. Science 1999;285:886-891.
63. Pyronnet S, Imataka H, Gingras A, Fukunaga R, Hunter T, Sonenberg N. Human eukaryotic translation initiation factor 4G (eIF4G) recruits mnk1 to phosphorylate eIF4E. EMBO J 1999;18:270-279.
64. Lavoie J, L'Allemain G, Brunet A, Muller R, Pouyssegur J. Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway. J Biol Chem 1996;271:20608-20616.
65. Thornberry N, Rano T, Peterson E, Rasper D, Timkey T, Garcia-Calvo M, Houtzager VM, et al. A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis. J Biol Chem 1997;272:17907-17911.
66. Blanchard H, Donepudi M, Tschopp M, Kodandapani L, Wu JC, Grutter M. Caspase-8 specificity probed at subsite S(4): crystal structure of the caspase-8-Z-DEVD-cho complex. J Mol Biol 2000;302:9-16.
67. Lee F, Hagler J, Chen Z, Maniatis T. Activation of the I kappa B alpha kinase complex by MEKK1, a kinase of the JNK pathway. Cell 1997;88: 213-222.
68. Joza N, Susin SA, Daugas E, Stanford WL, Cho SK, Li CY, Sasaki T, et al. Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death. Nature 2001;410:549-554.
69. Thornberry N, Lazebnik Y. Caspases: enemies within. Science 1998;281: 1312-1316.
70. Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S. The protein kinase complement of the human genome. Science 2002;298: 1912-1934.